Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child

Pediatric Transplantation

Volumn 11, Issue 6, 2007, Pages 671-675

  Hayashida, Makoto ^a   Ogita, Keiko ^a   Matsuura, Toshiharu ^a   Takahashi, Yukiko ^a   Nishimoto, Yuko ^a   Ohga, Shouichi ^a   Hara, Toshiro ^a   Soejima, Yuji ^a   Taketomi, Akinobu ^a   Maehara, Yoshihiko ^a   Kohashi, Kenichi ^a   Tsuneyoshi, Masazumi ^a   Taguchi, Tomoaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

EBV; LDLT; PTLD; Rituximab

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CD20 ANTIBODY; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS;

ARTICLE; B LYMPHOCYTE; BILE DUCT ATRESIA; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LAPAROTOMY; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; PORTOENTEROSTOMY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRESCHOOL CHILD; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INFANT; LIVER TRANSPLANTATION; LIVING DONORS; LYMPHOPROLIFERATIVE DISORDERS; REMISSION INDUCTION; TIME FACTORS;

EID: 34547477604     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00714.x     Document Type: Article

References (21)

1. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus (EBV) induced B-cell lymphoma after renal transplantation. N Engl J Med 1982 : 306 : 913 918.
2. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984 : 1 : 583 587.
3. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988 : 71 : 1234 1243.
4. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995 : 59 : 524 529.
5. Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 : 68 : 1851 1854.
6. Dror Y, Greenberg M, Taylor G, et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation 1999 : 67 : 990 998.
7. Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M. Posttransplantation lymphoproliferative disorder in children: Clinical, histopathologic, and imaging features. Radiology 2000 : 217 : 16 25.
8. Boyle GJ, Michaels MG, Webber SA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 1997 : 131 : 309 313.
9. Younes BS, Ament ME, McDiarmid SV, Martin MG, Vargas JH. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1999 : 28 : 380 385.
10. Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology 1999 : 213 : 73 78.
11. Hachem RR, Chakinala MM, Yusen RD, et al. Abdominal-pelvic lymphoproliferative disease after lung transplantation: Presentation and outcome. Transplantation 2004 : 77 : 431 437.
12. Smets F, Sokal EM. Epstein-Barr virus-related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and management. Pediatr Transplant 2002 : 6 : 280 287.
13. Campbell P, Marcus R. Monoclonal antibody therapy for lymphoma. Blood Rev 2003 : 17 : 143 152.
14. Oertel SHK, Verschuuren E, Reinke P, et al. Effect of anti-CD20 antibody rituximab in patients with post-transplant lymphoproliferative disorder. Am J Transpl 2005 : 5 : 2901 2906.
15. Tsai DE, Hardy CL, Tomaszewski JE, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001 : 71 : 1076 1088.
16. Buell JF, Gross TG, Hanaway MJ, et al. Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry experience. Transplant Proc 2005 : 37 : 956 957.
17. Berney T, Delis S, Kato T, et al. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation 2002 : 74 : 1000 1006.
18. Kostakoglu L, Leonard JP, Coleman M, Goldsmith SJ. The role of FDG-PET imaging in the management of lymphoma. Clin Adv Hematol Oncol 2004 : 2 : 115 121.
19. Messa C, Bettinardi V, Picchio M, et al. PET/CT in diagnostic oncology. Q J Nucl Med Mol Imaging 2004 : 48 : 66 75.
20. McCormack L, Hany TI, Hubner M, et al. How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? Am J Transplant 2006 : 6 : 1731 1736.
21. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: A potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 1999 : 26 : 1345 1348.